A Dark Vector Cognition product

Item 16. FORM 10-K SUMMARY

3K characters. Original on sec.gov ·

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

HUMANA INC.
By:/s/ BRIAN A. KANE
Brian A. Kane
Chief Financial Officer (Principal Financial Officer)
Date:February 21, 2019

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the date indicated.

SignatureTitleDate
/s/ BRIAN A. KANEChief Financial Officer (Principal Financial Officer)February 21, 2019
Brian A. Kane
/s/ CYNTHIA H. ZIPPERLESenior Vice President and Chief Accounting Officer (Principal Accounting Officer)February 21, 2019
Cynthia H. Zipperle
/s/ BRUCE D. BROUSSARDPresident and Chief Executive Officer, Director (Principal Executive Officer)February 21, 2019
Bruce D. Broussard
/s/ KURT J. HILZINGERChairman of the BoardFebruary 21, 2019
Kurt J. Hilzinger
/s/ FRANK BISIGNANODirectorFebruary 21, 2019
Frank Bisignano
/s/ KAREN DESALVO MD, MPH, MScDirectorFebruary 21, 2019
Karen DeSalvo, MD, MPH, MSc
/s/ FRANK A. D’AMELIODirectorFebruary 21, 2019
Frank A. D’Amelio
/s/ W. ROY DUNBARDirectorFebruary 21, 2019
W. Roy Dunbar
/s/ DAVID A. JONES, JR.DirectorFebruary 21, 2019
David A. Jones, Jr.
/s/ WILLIAM J. MCDONALDDirectorFebruary 21, 2019
William J. McDonald
/s/ WILLIAM E. MITCHELLDirectorFebruary 21, 2019
William E. Mitchell
/s/ DAVID B. NASH, M.D.DirectorFebruary 21, 2019
David B. Nash, M.D.
/s/ JAMES J. O’BRIENDirectorFebruary 21, 2019
James J. O’Brien
/s/ MARISSA T. PETERSONDirectorFebruary 21, 2019
Marissa T. Peterson

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES